Regencell Bioscience Holdings Ltd
RGCFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Regencell Bioscience Holdings Ltd Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 7 annual periods. The latest annual period ends Jun 30, 2025. The latest insider filing shown is dated May 29, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-05-27 | LO WILLIAM WING YAN DR · Director | Stock option (right to purchase) | D — Disposition to the issuer | −70,600 | SEC filing |
| 2026-05-27 | HUI EVANA YEE WAH · Director | Stock option (right to purchase) | D — Disposition to the issuer | −19,000 | SEC filing |
Showing 2 of 2 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.